Rolling Out47m
Ultherapy revolutionizes skin tightening with powerful results
Uncover how Ultherapy uses ultrasound to naturally lift and tighten skin, offering a powerful nonsurgical facelift ...
Vir Biotechnology Could Be An Early Riser In 2025 With Oncology Data In January
Vir Biotechnology's phase 3 hepatitis programs and cancer trials are on the horizon. Read why VIR stock could benefit from ...
Zacks.com on MSN5h
SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS
Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, ...
The American Journal of Managed Care5h
Updated Data Show Zongertinib Yields Responses in 71% With Previously Treated HER2-Mutated NSCLC
The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.
Medscape9h
‘Chance Finding’ a True Breakthrough for Spinal Cord Injury?
Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury ...
Sanofi's Tolebrutinib Gets FDA Breakthrough Therapy Designation For NrSPMS
French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...
Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDesignation is based on ...
Viruses Learn to Share: The Breakthrough Discovery Changing Phage Therapy
A new study reveals how a single species of bacteria can sustain a diverse community of phage species, with implications for ...
Breakthrough gene therapy for haemophilia: Why this Indian trial saves patients from repeat hospital visits, high costs
Patients report zero bleeding in clinical trial conducted by CMC, Vellore and the Center for Stem Cell Research, Bengaluru.
Vir gets FDA breakthrough therapy status for two drugs
Vir Biotechnology (NASDAQ:VIR) said its drugs tobevibart and elebsiran have received FDA Breakthrough Therapy designation for the treatment of chronic hepatitis delta. The drugs have also received ...